Back Article

  • [1]

    许可, 蒋春梅, 邓小昭, 丁伟良, 谈永飞, 张云, 2006: Study On the Variation of E2 of 1b Hepatitis C Virus in the South of Jiangsu Province, Virologica Sinica, 21, 333-338.

  • [2]

    Wen Deng, Hongxiao Hao, Ziyu Zhang, Xinxin Li, Weihua Cao, Yaqin Zhang, Shiyu Wang, Zixuan Gao, Linmei Yao, Shuojie Wang, Xin Wei, Wei Yi, Linqing Zhao, Yao Xie, Minghui Li, 2025: Clinical outcomes after HBsAg clearance in chronic hepatitis B patients treated with Peg-IFN α: A study with an 11- to 173-month follow-up, Virologica Sinica, 40, 579-586. doi: 10.1016/j.virs.2025.06.008

  • [3]

    饶敏, 张淑玲, 董继华, 李淑莉, 2006: Inhibition of Hepatitis B Virus Replication by Homoharringtonine, IFN-α1b, Hydroxycamptothecin and Norfloxacin, Virologica Sinica, 21, 284-287.

  • [4]

    冷彦, 陈秀珠, 杜勇, 毛春生, 杜桂鑫, 王海涛, 2001: Preliminary Study of Hepatitis C Viral Quasispecies in NS2 Region in Patients wiUl Hepatitis C Virus Infection, Virologica Sinica, 16, 215-219.

  • [5]

    郑义, 高博, 景维, 孔令保, 杨晓俊, 吴正辉, 叶林柏*, 2005: Hepatitis C Virus Non-structural Protein 4B Induces Unfolded Protein Response, Virologica Sinica, 20, 374-378.

  • [6]

    Mengxian Lin, Kunqi Chen, Hang Li, Xinjian Lin, Shuxiang Wu, Xu Lin, 2026: Hepatitis B virus promotes hepatocellular carcinoma progression by disrupting NSUN2/YBX1-mediated m5C modification of PTEN mRNA, Virologica Sinica, 41, 543-560. doi: 10.1016/j.virs.2026.03.001

  • [7]

    Baisong Zheng, Xiaolei Zhou, Li Tian, Jian Wang, Wenyan Zhang, 2022: IFN-β1b induces OAS3 to inhibit EV71 via IFN-β1b/JAK/STAT1 pathway, Virologica Sinica, 37, 676-684. doi: 10.1016/j.virs.2022.07.013

  • [8]

    许信刚, 胡建和, 张彦明, 邓宏魁, 2005: Construction of Hepatitis C Virus E1E2 Envelope Protein Gene DNA Vaccine and Animal Immune Experiment, Virologica Sinica, 20, 549-551.

  • [9]

    唐时幸, 王海涛, 鲍作义, 张习坦, 1995: A Skewed Light Chain Isotype Expression and B-Cell Clonal Dominance of Anti-HCV Response in Hepatitis C Virus Infection, Virologica Sinica, 10, 141-.

  • [10]

    Danrong Shi, Keda Chen, Xiangyun Lu, Linfang Cheng, Tianhao Weng, Fumin Liu, Nanping Wu, Lanjuan Li, Hangping Yao, 2022: Recombinant human interferon-α1b inhibits SARS-CoV-2 better than interferon-α2b in vitro, Virologica Sinica, 37, 295-298. doi: 10.1016/j.virs.2022.01.031

  • [11]

    Raouia ElFihry, Mohcine Elmessaoudi-Idrissi, Fatima-Zahra Jadid, Imane Zaidane, Hajar Chihab, Mohamed Tahiri, Mostafa Kabine, Wafaa Badre, Isabelle Chemin, Agnes Marchio, Pascal Pineau, Sayeh Ezzikouri, Soumaya Benjelloun, 2020: Effect of Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 Alpha Variants on Spontaneous Clearance and Fibrosis Progression during Hepatitis C Virus Infection in Moroccan Patients, Virologica Sinica, 35, 566-574. doi: 10.1007/s12250-020-00220-7

  • [12]

    郭统祥, 段发愚, 王雅珍, 吴常青, 梁经文, 邢文举, 宣香婵, 1989: Study on Small Dosages of HulFN--α (Le) Accompanied with Poly 1: C in the Treatment of Chronic Active Hepatitis, Virologica Sinica, 4, 320-.

  • [13]

    Tielong Chen, Yilan Hu, Quanquan Ding, Jing Yu, Fubing Wang, Fengling Luo, Xiao-Lian Zhang, 2015: Serum ficolin-2 concentrations are significantly changed in patients with hepatitis B virus infection and liver diseases, Virologica Sinica, 30, 249-260. doi: 10.1007/s12250-015-3605-4

  • [14]

    Xiaoping Chen, Qunqun Jiang, Zhiyong Ma, Jiaxin Ling, Wenjia Hu, Qian Cao, Pingzheng Mo, Lei Yao, Rongrong Yang, Shicheng Gao, Xien Gui, Wei Hou, Yong Xiong, Jinlin Li, Yongxi Zhang, 2020: Clinical Characteristics of Hospitalized Patients with SARS-CoV-2 and Hepatitis B Virus Co-infection, Virologica Sinica, 35, 842-845. doi: 10.1007/s12250-020-00276-5

  • [15]

    Lei Yu, Xinjin Liu, Xiaoqin Wei, Junrui Ren, Xueyun Wang, Shuwen Wu, Ke Lan, 2024: C1QTNF5 is a novel attachment factor that facilitates the entry of influenza A virus, Virologica Sinica, 39, 277-289. doi: 10.1016/j.virs.2024.01.003

  • [16]

    Xin-Cheng Qin, Li-Hua Zhong, Li-Ying Zhu, Alexander Plyusnin, Yong-Zhen Zhang, 2020: Hepatitis C Virus Infection Caused by Infrequent Exposure in China Should Be of Concern, Virologica Sinica, 35, 481-485. doi: 10.1007/s12250-019-00191-4

  • [17]

    何生松, 李淑莉, 熊莉娟, 刘薇, 曾令兰, 2000: A Study on the Relation between Changes of lnterleukin and Receptor in Serum in Patients with Chronic Hepatitis B and Action of Treatment with IFN.a, Virologica Sinica, 15, 342-345.

  • [18]

    陈元鼎, 刘名英, 李嘉琦, 赵玮, 彭梅, 周曾全, 余文霖, 李惠琼, 2000: New Nucleotide Sequences of the 5 Non-coding Region of Hepatitis C Virus Isolated from China, Virologica Sinica, 15, 136-142.

  • [19]

    Wenhua Shao, Wei Zhang, Zhitong Chen, Tingting Zhou, Xiaoyi Zhao, Hongyi Liu, Chuangwei Chen, Xingyan Dong, Weijun Cao, Zongsheng Zhao, Fan Yang, Zixiang Zhu, Haixue Zheng, 2026: STING1 negatively regulates translation and replication of foot-and-mouth disease virus independently of interferon and is antagonized by the viral proteins 3C and 2B, Virologica Sinica, 41, 355-370. doi: 10.1016/j.virs.2026.04.007

  • [20]

    Xuechao Zhao, Lingyu Qian, Deyu Zhou, Di Qi, Chang Liu, Xiaohong Kong, 2016: Stability of HIV-1 subtype B and C Tat is associated with variation in the carboxyl-terminal region, Virologica Sinica, 31, 199-206. doi: 10.1007/s12250-016-3681-0